- Home
- DEC vs TRVI Comparison
DEC vs TRVI Comparison
Compare DEC & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEC
- TRVI
- Stock Information
- Founded
- DEC 2001
- TRVI 2011
- Country
- DEC United States
- TRVI United States
- Employees
- DEC N/A
- TRVI N/A
- Industry
- DEC
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- DEC
- TRVI Health Care
- Exchange
- DEC Nasdaq
- TRVI Nasdaq
- Market Cap
- DEC 884.9M
- TRVI 725.7M
- IPO Year
- DEC N/A
- TRVI 2019
- Fundamental
- Price
- DEC $15.04
- TRVI $7.01
- Analyst Decision
- DEC Strong Buy
- TRVI Strong Buy
- Analyst Count
- DEC 4
- TRVI 10
- Target Price
- DEC $21.50
- TRVI $19.35
- AVG Volume (30 Days)
- DEC 309.3K
- TRVI 2.0M
- Earning Date
- DEC 01-01-0001
- TRVI 11-05-2025
- Dividend Yield
- DEC 5.39%
- TRVI N/A
- EPS Growth
- DEC N/A
- TRVI N/A
- EPS
- DEC N/A
- TRVI N/A
- Revenue
- DEC $1,148,432,000.00
- TRVI N/A
- Revenue This Year
- DEC $124.30
- TRVI N/A
- Revenue Next Year
- DEC $2.00
- TRVI N/A
- P/E Ratio
- DEC N/A
- TRVI N/A
- Revenue Growth
- DEC 64.19
- TRVI N/A
- 52 Week Low
- DEC $10.08
- TRVI $2.36
- 52 Week High
- DEC $17.70
- TRVI $8.78
- Technical
- Relative Strength Index (RSI)
- DEC 42.67
- TRVI 44.05
- Support Level
- DEC $14.96
- TRVI $7.09
- Resistance Level
- DEC $16.61
- TRVI $8.78
- Average True Range (ATR)
- DEC 0.40
- TRVI 0.43
- MACD
- DEC -0.11
- TRVI -0.07
- Stochastic Oscillator
- DEC 4.22
- TRVI 4.32
About DEC Diversified Energy Company plc
Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.